Alfresa Holdings Corporation (2784)

Name: Alfresa Holdings Corporation (2784) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Healthcare · Wall Street (EUA) · Última atualização: 2026-09-21

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. The company operates through Wholesale of Prescription Drugs and Related Products, Wholesale of Self-Medication Products, Manufacturing of Pharmaceuticals and Related Products, and Pharmacy and Related Businesses segments.

Números-chave

Capitalização de mercado: JPY 413 billion
Receita (exercício encerrado em 2026-03-31): JPY 3.10T
Lucro líquido: JPY 41.7B
Margem bruta: 7.0%
Margem líquida: 1.3%

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Receita total	JPY 3.10T	JPY 2.96T	JPY 2.86T	JPY 2.70T	—
Lucro bruto	JPY 217.9B	JPY 213.9B	JPY 206.4B	JPY 192.1B	—
Resultado Operacional (EBIT)	JPY 36.2B	JPY 38.1B	JPY 38.5B	JPY 30.1B	—
Resultado líquido	JPY 41.7B	JPY 27.4B	JPY 29.6B	JPY 25.8B	—

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 2784. /companies/us/2784

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.